Printer Friendly Version  View printer-friendly version
<< Back
Array BioPharma to Present at the Leerink Swann Cancer RoundtableConference

BOULDER, Colo., Mar 29, 2011 (BUSINESS WIRE) --

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Cancer Roundtable Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.


Leerink Swann Cancer Roundtable Conference


Robert E. Conway, Chief Executive Officer, Array BioPharma


Thursday, April 7, 2011


11:20 a.m. Eastern Time


Roosevelt Hotel, New York, NY


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
ShareThis Copy and Paste